Key Drivers
- Strong Margins
- Solid Liquidity
- High Leverage
AIAI Summary
ZTS has shifted from a premium compounder to a quality-under-stress story, with the investment case now hinging on whether international and livestock growth can offset softer U.S. companion-animal demand and protect margins after the guidance cut.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Margins
- •Solid Liquidity
- •High Leverage
ZTS shows excellent profitability, margins, and liquidity, but its meaningful leverage and still-rich valuation warrant caution despite healthy cash generation.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Weak support
- •Oversold bounce
ZTS has dropped nearly 39% over the last month, remains in a clear downtrend with support at $74-$76, and must reclaim $82.83 then $87.31 to meaningfully improve the short-term setup.
Sharp break from $111.22 to $87.31, followed by continued downside pressure
Sentiment & News
Key News Insights:
- •Value rerating
- •Guidance cut
- •Legal scrutiny
Zoetis went from value-driven optimism to a sharp post-earnings selloff after missing Q1 estimates and cutting 2026 revenue guidance, triggering shareholder-law investigations.
The earnings miss and reduced outlook have turned sentiment bearish and may keep pressure on the shares until growth visibility improves
Similar Companies in Healthcare
Other companies in the same sector with AI ratings